Table 1 Summary characteristics of included studies
Characteristics | Median value (IQR)/cumulative no. of studies (no. of patients) |
|---|---|
Eligible studies | Â |
 Total no. of studies (no. of patients) | 26 (25189) |
  Prospective | 10 (3552) |
  Retrospective | 16 (21637) |
 Mortality, median (IQR) % |  |
  All-cause hospital mortality | 21.9 (15.2–29.3) |
  All-cause long-term mortality | 35.9 (28.9–43.2) |
 Median (IQR) %, male | 63.5 (61–70.8) |
 Median (IQR), age (years) | 58.1 (53.9–64) |
 Median (IQR) follow-up (days) | 30 (24–60) |
Country | Â |
 America | 6 (889) |
 Australia | 3 (476) |
 China | 8 (3185) |
 Estonia | 1 (1712) |
 France | 1 (153) |
 Greece | 1 (46) |
 Iran | 2 (395) |
 New Zealand | 1 (455) |
 Spain | 1 (72) |
 Multinational | 2 (17806) |
Diseases/patient state, median (IQR) % | Â |
 Surgery | 0 (0–21.3) |
 Trauma | 19 (14–54) |
 Burns | 55 (8.8–100) |
 Digestive | 7 (3–9.5) |
 Sepsis | 29 (12–100) |
 Mechanical ventilation | 100 (82–100) |
FI definitions | Â |
 Defined by GISs | 22 (8441) |
 Defined by large GRV | 8 (1381) |
 Defined by EF insufficiency | 8 (3855) |
 Defined by no. of GISs | 16 (7399) |
 Defined by a specific symptom | 12 (2370) |